Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where David J. Madar is active.

Publication


Featured researches published by David J. Madar.


Journal of Medicinal Chemistry | 2015

Structure-guided design of a series of MCL-1 inhibitors with high affinity and selectivity.

Milan Bruncko; Le Wang; George S. Sheppard; Darren C. Phillips; Stephen K. Tahir; John Xue; Scott A. Erickson; Steve D. Fidanze; Elizabeth E. Fry; Lisa A. Hasvold; Gary J. Jenkins; Sha Jin; Russell A. Judge; Peter Kovar; David J. Madar; Paul Nimmer; Chang Park; Andrew M. Petros; Saul H. Rosenberg; Morey L. Smith; Xiaohong Song; Chaohong Sun; Zhi-Fu Tao; Xilu Wang; Yu Xiao; Haichao Zhang; Chris Tse; Joel D. Leverson; Steve W. Elmore; Andrew J. Souers

Myeloid cell leukemia 1 (MCL-1) is a BCL-2 family protein that has been implicated in the progression and survival of multiple tumor types. Herein we report a series of MCL-1 inhibitors that emanated from a high throughput screening (HTS) hit and progressed via iterative cycles of structure-guided design. Advanced compounds from this series exhibited subnanomolar affinity for MCL-1 and excellent selectivity over other BCL-2 family proteins as well as multiple kinases and GPCRs. In a MCL-1 dependent human tumor cell line, administration of compound 30b rapidly induced caspase activation with associated loss in cell viability. The small molecules described herein thus comprise effective tools for studying MCL-1 biology.


Tetrahedron Letters | 2001

Synthesis of N-arylated oxazolidinones via a palladium catalyzed cross coupling reaction. Application to the synthesis of the antibacterial agent Dup-721

David J. Madar; Hana Kopecka; Daisy Pireh; Jonathan Pease; Marina Pliushchev; Richard J. Sciotti; Paul E. Wiedeman; Stevan W. Djuric

Abstract A method for the intermolecular coupling of aryl bromides and oxazolidinones is described. Application to intermediates useful for the preparation of a known class of antibacterial agent and the synthesis of the known antibacterial oxazolidinone Dup-721 are described.


Tetrahedron Letters | 1993

Towards the synthesis of streptovaricin D: Synthesis of fully elaborated aromatic precursors and coupling with ansa chain fragments

William R. Roush; David J. Madar

Abstract The highly functionalized streptovaricin-damavaricin D aromatic precursors 12 and 15 have been prepared and coupled with propionaldehyde or unsaturated aldehydes 16 and 18 via aryllithium intermediates to give 2, 3 and 19.


Journal of Medicinal Chemistry | 2000

3,5-Bis(trifluoromethyl)pyrazoles: A Novel Class of NFAT Transcription Factor Regulator

Stevan W. Djuric; Nwe Y. BaMaung; Basha A; Liu H; Luly; David J. Madar; Sciotti Rj; Tu Np; Wagenaar Fl; Paul E. Wiedeman; Zhou X; Stephen J. Ballaron; Joy Bauch; Chen Yw; Chiou Xg; Thomas A. Fey; Donna M. Gauvin; Gubbins E; Gin C. Hsieh; Kennan C. Marsh; Karl W. Mollison; Pong M; Shaughnessy Tk; Sheets Mp; Morey L. Smith; James M. Trevillyan; Usha Warrior; Wegner Cd; George W. Carter


Archive | 2001

Oxazolidinone antibacterial agents

David J. Madar; Daisy Pireh; Hana Kopecka; Steven W. Djuric; Paul E. Wiedeman


Archive | 1999

Azole inhibitors of cytokine production

Nwe Y. BaMaung; Anwer Basha; Stevan W. Djuric; Earl J. Gubbins; Jay R. Luly; Noah P. Tu; David J. Madar; Usha Warrior; Paul E. Wiedeman; Xun Zhou; Richard J. Sciotti; Frank L. Wagenaar


Archive | 2008

Treatment of central nervous system disorders

R. Scott Bitner; Kaitlin E. Browman; Michael E. Brune; Yixian Chen; Jurgen Dinges; Karla Drescher; Peer B. Jacobson; Hwan-Soo Jae; Ravi Kurukulasuriya; James T. Link; David J. Madar; Jyoti R. Patel; Marina A. Pliushchev; Jeffrey J. Rohde; Lynne E. Rueter; Qi Shuai; Bryan K. Sorensen; Jiahong Wang; Karsten Wicke; Martin Winn; Dariusz Wodka; Vince Yeh; Hong Yong


Journal of Medicinal Chemistry | 2006

Discovery, structure-activity relationship, and pharmacological evaluation of (5-substituted-pyrrolidinyl-2-carbonyl)-2-cyanopyrrolidines as potent dipeptidyl peptidase IV inhibitors.

Zhonghua Pei; Xiaofeng Li; Kenton L. Longenecker; Thomas W. von Geldern; Paul E. Wiedeman; Thomas H. Lubben; Bradley A. Zinker; Kent D. Stewart; Stephen J. Ballaron; Michael A. Stashko; Amanda K. Mika; David W. A. Beno; Michelle A. Long; Heidi Wells; Anita J. Kempf-Grote; David J. Madar; Todd S. McDermott; Lakshmi Bhagavatula; Michael G. Fickes; Daisy Pireh; Larry R. Solomon; Marc R. Lake; Rohinton Edalji; Elizabeth H. Fry; Hing L. Sham; James M. Trevillyan


Archive | 2008

7-substituted indole mcl-1 inhibitors

Xilu Wang; Xiaohong Song; Steven W. Elmore; Milan Bruncko; David J. Madar; Andrew J. Souers; Lisa A. Hasvold; Le Wang; Zhi-Fu Tao; Aaron R. Kunzer


Biochemistry | 2006

Crystal structures of DPP-IV (CD26) from rat kidney exhibit flexible accommodation of peptidase-selective inhibitors

Kenton L. Longenecker; Kent D. Stewart; David J. Madar; Clarissa Jakob; Elizabeth H. Fry; Sherwin Wilk; Chun W. Lin; Stephen J. Ballaron; Michael A. Stashko; Thomas H. Lubben; Hong Yong; Daisy Pireh; Zhonghua Pei; Fatima Z. Basha; Paul E. Wiedeman; Thomas W. von Geldern; and James M. Trevillyan; Vincent S. Stoll

Collaboration


Dive into the David J. Madar's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Richard J. Sciotti

Indiana University Bloomington

View shared research outputs
Top Co-Authors

Avatar

Stevan W. Djuric

Albert Einstein College of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Michael A. Stashko

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors

Avatar

Thomas H. Lubben

University of Wisconsin-Madison

View shared research outputs
Top Co-Authors

Avatar

James M. Trevillyan

Albert Einstein College of Medicine

View shared research outputs
Researchain Logo
Decentralizing Knowledge